Raquel Ordonez

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.

Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.

Journal: Journal of cellular physiology
Published: February 04, 2024

An automated network-based tool to search for metabolic vulnerabilities in cancer.

An automated network-based tool to search for metabolic vulnerabilities in cancer.

Journal: Nature communications
Published: June 22, 2022

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.

Journal: Nature medicine
Published: February 02, 2022

Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts.

Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts.

Journal: American journal of hematology
Published: September 09, 2021

The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome.

The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome.

Journal: Nature cancer
Published: June 03, 2021

Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.

Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.

Journal: Journal of medicinal chemistry
Published: March 04, 2021

Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma.

Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma.

Journal: Leukemia
Published: June 25, 2020

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma.

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma.

Journal: Genome research
Published: May 08, 2020

Correction: Ordoñez, et al.; DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters? Cancers 2019, 11, 1424.

Correction: Ordoñez, et al.; DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters? Cancers 2019, 11, 1424.

Journal: Cancers
Published: April 29, 2020

DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?

DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?

Journal: Cancers
Published: August 22, 2019

Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated.

Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated.

Journal: Haematologica
Published: August 23, 2018

Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.

Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.

Journal: Journal of medicinal chemistry
Published: June 29, 2018
Showing 1-12 of 25

Last Updated: 09/26/2026